Study reveals antibiotic use is not the only driver of antibiotic resistance
Researchers compared 20 years of antibiotic use on E. coli in the UK and Norway
Read More
Tag: antibiotic resistance
Antibiotic Research UK launches small research grants programme
Charity will award grants for research projects into antibiotics and antibiotic resistance
Read More
Destiny Pharma’s novel antibiotic asset clears safety review
Independent Data Monitoring Committee recommended continuing Phase IIb study
Read More
NICE, PHE publish antimicrobial prescribing guidance on pneumonia
New recommendations have been added to highlight that antibiotic treatment should be started as soon as possible – no more than four hours after diagnosis and one hour if sepsis is suspected.
Read More
New NICE guidelines on antibiotic prescribing for pneumonia
The National Institute for Health and Care Excellence (NICE) and Public Health England (PHE) have published draft guidance on antimicrobial prescribing for hospital-acquired and community-acquired pneumonia, setting out a strategy designed to optimise antibiotic use and reduce antibiotic resistance.
Read More
IND status for MGB Biopharma’s CDAD drug
The Food and Drug Administration (FDA) and Health Canada have cleared Investigational New Drug applications (IND) for MGB Biopharma’s lead candidate MGB-BP-3, for the treatment of clostridium difficile-associated diarrhoea.
Read More
Ulster University research to tackle ‘super-acne’
Researchers at Ulster University are leading a three-year research programme which hopes to find new ways of treating antibiotic resistant acne.
Read More
UN signs historic declaration to fight AMR
A historic declaration to combat antimicrobial resistance has been signed by 193 countries at a United Nations General Assembly.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
